BACKGROUND: The retinal vasculature may be altered in multiple sclerosis (MS), potentially acting as a biomarker of disease processes. OBJECTIVE: To compare retinal vascular plexus densities in people with MS (PwMS) and healthy controls (HCs), and examine correlations with visual function and global disability. METHODS: In this cross-sectional study, 111 PwMS (201 eyes) and 50 HCs (97 eyes) underwent optical coherence tomography angiography (OCTA). Macular superficial vascular plexus (SVP) and deep vascular plexus (DVP) densities were quantified, and poor quality images were excluded according to an artifact-rating protocol. RESULTS: Mean SVP density was 24.1% (SD = 5.5) in MS eyes (26.0% (SD = 4.7) in non-optic neuritis (ON) eyes vs. 21.7% (SD = 5.5) in ON eyes, p < 0.001), as compared to 29.2% (SD = 3.3) in HC eyes (p < 0.001 for all MS eyes and multiple sclerosis optic neuritis (MSON) eyes vs. HC eyes, p = 0.03 for MS non-ON eyes vs. HC eyes). DVP density did not differ between groups. In PwMS, lower SVP density was associated with higher levels of disability (expanded disability status scale (EDSS): R2 = 0.26, p = 0.004; multiple sclerosis functional composite (MSFC): R2 = 0.27, p = 0.03) and lower letter acuity scores (100% contrast: R2 = 0.29; 2.5% contrast: R2 = 0.40; 1.25% contrast: R2 = 0.31; p < 0.001 for all). CONCLUSIONS: Retinal SVP density measured by OCTA is reduced across MS eyes, and correlates with visual function, EDSS, and MSFC scores.
BACKGROUND: The retinal vasculature may be altered in multiple sclerosis (MS), potentially acting as a biomarker of disease processes. OBJECTIVE: To compare retinal vascular plexus densities in people with MS (PwMS) and healthy controls (HCs), and examine correlations with visual function and global disability. METHODS: In this cross-sectional study, 111 PwMS (201 eyes) and 50 HCs (97 eyes) underwent optical coherence tomography angiography (OCTA). Macular superficial vascular plexus (SVP) and deep vascular plexus (DVP) densities were quantified, and poor quality images were excluded according to an artifact-rating protocol. RESULTS: Mean SVP density was 24.1% (SD = 5.5) in MS eyes (26.0% (SD = 4.7) in non-optic neuritis (ON) eyes vs. 21.7% (SD = 5.5) in ON eyes, p < 0.001), as compared to 29.2% (SD = 3.3) in HC eyes (p < 0.001 for all MS eyes and multiple sclerosis optic neuritis (MSON) eyes vs. HC eyes, p = 0.03 for MS non-ON eyes vs. HC eyes). DVP density did not differ between groups. In PwMS, lower SVP density was associated with higher levels of disability (expanded disability status scale (EDSS): R2 = 0.26, p = 0.004; multiple sclerosis functional composite (MSFC): R2 = 0.27, p = 0.03) and lower letter acuity scores (100% contrast: R2 = 0.29; 2.5% contrast: R2 = 0.40; 1.25% contrast: R2 = 0.31; p < 0.001 for all). CONCLUSIONS: Retinal SVP density measured by OCTA is reduced across MS eyes, and correlates with visual function, EDSS, and MSFC scores.
Authors: Stephanie B Syc; Christina V Warner; Girish S Hiremath; Sheena K Farrell; John N Ratchford; Amy Conger; Teresa Frohman; Gary Cutter; Laura J Balcer; Elliot M Frohman; Peter A Calabresi Journal: Mult Scler Date: 2010-06-08 Impact factor: 6.312
Authors: Marcus Koch; Geeta S M Ramsaransing; Alexander V Arutjunyan; Michael Stepanov; Albert Teelken; Dorothea J Heersema; Jacques De Keyser Journal: J Neurol Date: 2005-11-14 Impact factor: 4.849
Authors: Andrew Lang; Aaron Carass; Omar Al-Louzi; Pavan Bhargava; Sharon D Solomon; Peter A Calabresi; Jerry L Prince Journal: Proc SPIE Int Soc Opt Eng Date: 2016-03-21
Authors: Natalia Gonzalez Caldito; Bhavna Antony; Yufan He; Andrew Lang; James Nguyen; Alissa Rothman; Esther Ogbuokiri; Ama Avornu; Laura Balcer; Elliot Frohman; Teresa C Frohman; Pavan Bhargava; Jerry Prince; Peter A Calabresi; Shiv Saidha Journal: Curr Eye Res Date: 2017-12-14 Impact factor: 2.424
Authors: Meng Law; Amit M Saindane; Yulin Ge; James S Babb; Glyn Johnson; Lois J Mannon; Joseph Herbert; Robert I Grossman Journal: Radiology Date: 2004-06 Impact factor: 11.105
Authors: Ellen M Mowry; Christina J Azevedo; Charles E McCulloch; Darin T Okuda; Robin R Lincoln; Emmanuelle Waubant; Stephen L Hauser; Daniel Pelletier Journal: Neurology Date: 2018-11-14 Impact factor: 11.800
Authors: Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman Journal: Prog Retin Eye Res Date: 2021-01-15 Impact factor: 19.704
Authors: Beatriz Cordon; Elisa Vilades; Elvira Orduna; María Satue; Javier Perez-Velilla; Berta Sebastian; Vicente Polo; Jose Manuel Larrosa; Luis Emilio Pablo; Elena Garcia-Martin Journal: PLoS One Date: 2020-12-08 Impact factor: 3.240
Authors: Olwen C Murphy; Grigorios Kalaitzidis; Eleni Vasileiou; Angeliki G Filippatou; Jeffrey Lambe; Henrik Ehrhardt; Nicole Pellegrini; Elias S Sotirchos; Nicholas J Luciano; Yihao Liu; Kathryn C Fitzgerald; Jerry L Prince; Peter A Calabresi; Shiv Saidha Journal: Front Neurol Date: 2020-12-15 Impact factor: 4.003
Authors: Axel Petzold; Philipp Albrecht; Laura Balcer; Erik Bekkers; Alexander U Brandt; Peter A Calabresi; Orla Galvin Deborah; Jennifer S Graves; Ari Green; Pearse A Keane; Jenny A Nij Bijvank; Josemir W Sander; Friedemann Paul; Shiv Saidha; Pablo Villoslada; Siegfried K Wagner; E Ann Yeh Journal: Ann Clin Transl Neurol Date: 2021-05-19 Impact factor: 4.511